All-case Japanese post-marketing surveillance of the real-world safety and efficacy of rituximab treatment in patients with refractory nephrotic syndrome

por Kobayashi, Mana, Kageyama, Yutaro, Ando, Takashi, Sakamoto, Junko, Kimura, Shohji
Publicado 2021

ASBEL, an ANA/BTG3 antisense transcript required for tumorigenicity of ovarian carcinoma

por Yanagida, Satoshi, Taniue, Kenzui, Sugimasa, Hironobu, Nasu, Emiko, Takeda, Yasuko, Kobayashi, Mana, Yamamoto, Tadashi, Okamoto, Aikou, Akiyama, Tetsu
Publicado 2013

PIK3CA and KRAS mutations in cell free circulating DNA are useful markers for monitoring ovarian clear cell carcinoma

por Morikawa, Asuka, Hayashi, Tomoatsu, Shimizu, Naomi, Kobayashi, Mana, Taniue, Kenzui, Takahashi, Akiko, Tachibana, Kota, Saito, Misato, Kawabata, Ayako, Iida, Yasushi, Ueda, Kazu, Saito, Motoaki, Yanaihara, Nozomu, Tanabe, Hiroshi, Yamada, Kyosuke, Takano, Hirokuni, Nureki, Osamu, Okamoto, Aikou, Akiyama, Tetsu
Publicado 2018